Gensight Biologics SA (SIGHT) — Financial Flexibility Index
Gensight Biologics SA (SIGHT) has a Financial Flexibility Index of 0.00x as of December 2025. Free cash flow of €0.00 (operating CF €-6.49 Million minus capex €6.49 Million) represents 0% of total liabilities (€33.20 Million). Check Gensight Biologics SA (SIGHT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gensight Biologics SA Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Gensight Biologics SA across 13 annual periods. For the full cash flow conversion analysis, see SIGHT cash flow conversion.
Annual Financial Flexibility Index for Gensight Biologics SA (2013–2025)
Year-by-year free cash flow to debt coverage for Gensight Biologics SA. Explore SIGHT operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | €-9.37 Million | €-9.38 Million | €33.20 Million | ▲ +17.8% |
| 2024 | -0.34x | €-12.94 Million | €-12.94 Million | €37.68 Million | ▲ +44.5% |
| 2023 | -0.62x | €-24.65 Million | €-24.66 Million | €39.83 Million | ▲ +23.9% |
| 2022 | -0.81x | €-33.50 Million | €-33.75 Million | €41.22 Million | ▼ -93.2% |
| 2021 | -0.42x | €-17.11 Million | €-17.14 Million | €40.66 Million | ▲ +0.1% |
| 2020 | -0.42x | €-15.04 Million | €-15.04 Million | €35.69 Million | ▲ +68.8% |
| 2019 | -1.35x | €-28.04 Million | €-28.11 Million | €20.74 Million | ▲ +35.8% |
| 2018 | -2.10x | €-27.59 Million | €-28.38 Million | €13.11 Million | ▲ +18.1% |
| 2017 | -2.57x | €-18.55 Million | €-18.78 Million | €7.22 Million | ▲ +22.2% |
| 2016 | -3.30x | €-19.45 Million | €-19.64 Million | €5.89 Million | ▼ -102.5% |
| 2015 | -1.63x | €-11.39 Million | €-12.09 Million | €6.98 Million | ▼ -29.7% |
| 2014 | -1.26x | €-5.33 Million | €-5.52 Million | €4.24 Million | ▼ -49.1% |
| 2013 | -0.84x | €-1.61 Million | €-1.95 Million | €1.91 Million | — |